Contact

Click here for a confidential contact or call:

1-347-417-2192

Archive

Page 4 of 4

Sleep-Disorder Fraud

Posted  09/22/15
Can one commit fraud while sleeping?  Sort of. Increasing numbers of troubled sleepers are seeking diagnosis and treatment of chronic sleep disorders that affect more than fifty million Americans.  The significant growth in sleep medicine over recent years brings increasing opportunities for the unscrupulous to engage in fraudulent services and billing The most common method of diagnosing sleep disorders is a...

DOJ Catch Of The Week -- Orbit Medical/Rehab Medical

Posted  05/29/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "catch of the week" goes to Orbit Medical Inc. and its partial successor, Rehab Medical Inc.  On Wednesday, these durable medical equipment suppliers agreed to pay $7.5 million to settle False Claims Act charges that Orbit submitted false claims to federal health care programs for power wheelchairs and accessories.  See DOJ Press...

DOJ Catch Of The Week — Medtronic

Posted  04/3/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "catch of the week" goes to medical device maker Medtronic plc and affiliated Medtronic companies, Medtronic Inc., Medtronic USA Inc., and Medtronic Sofamor Danek USA Inc.  Yesterday, the companies agreed to pay $4.4 million to resolve allegations they violated the False Claims Act by making false statements to the Department of Veterans...

DOJ Catch of the Week – Vascular Solutions

Posted  08/1/14
By the C|C Whistleblower Lawyer Team This week's Department of Justice "catch of the week" goes to Vascular Solutions Inc (VSI).  On Monday, the Minneapolis-based medical device maker agreed to pay $520,000 to resolve allegations that it violated the False Claims Act by marketing a product for sealing veins without FDA approval.  Specifically, the government charged that VSI marketed and sold its "Vari-Lase...

Fudging the Studies -- Senate Report Links Medtronic to Latest Case of Ghostwriting Medical Journal Articles

Posted  11/9/12
By Gordon Schnell  In a scathing report it recently released, the Senate Finance Committee charged medical device manufacturer Medtronic, Inc. with engaging in some fairly dastardly deeds to promote its once top-selling bone growth product called InFuse.  The alleged misconduct centers around the company paying off doctors to author medical journal pieces that downplayed or downright ignored serious risks and...